Silvant Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,120
Closed -$241K 343
2019
Q1
$241K Hold
2,120
0.04% 172
2018
Q4
$83K Hold
2,120
0.02% 235
2018
Q3
$116K Hold
2,120
0.01% 227
2018
Q2
$175K Hold
2,120
0.02% 207
2018
Q1
$141K Buy
+2,120
New +$141K 0.02% 221